Lansoprazole Capsule, Delayed Release
Product Images NDC 68788-7742

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Lansoprazole (NDC 68788-7742). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Preferred Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Lansoprazole Delayed Release Capsules Usp 30mg

Lansoprazole Delayed-Release Capsule USP 30 mg label from Preferred Pharmaceuticals, Inc. The label states it is generic for Prevacid and each capsule contains 30 mg Lansoprazole. It includes storage instructions, a warning to keep out of reach of children, and recommends use as directed by a doctor. The label also features directions in English and Spanish and barcode information.*

FDA Label Image

F53ca2be-a290-4157-ad95-d24dfe3344f9-01 (F53ca2be A290 4157 Ad95 D24dfe3344f9 01)

Chemical structure of Lansoprazole, illustrating the molecular arrangement including a benzimidazole ring, sulfoxide group, and pyridine ring with trifluoromethoxy substitution.*

FDA Label Image

F53ca2be-a290-4157-ad95-d24dfe3344f9-02 (F53ca2be A290 4157 Ad95 D24dfe3344f9 02)

A line graph titled 'Mean Severity of Day Heartburn By Study Day For Evaluable Patients' shows mean heartburn severity scores (scale 0 to 3) over approximately 60 days from treatment start. It compares placebo, Lansoprazole 15 mg once daily, and Lansoprazole 30 mg once daily, illustrating a decrease in heartburn severity for both Lansoprazole doses compared to placebo.*

FDA Label Image

F53ca2be-a290-4157-ad95-d24dfe3344f9-03 (F53ca2be A290 4157 Ad95 D24dfe3344f9 03)

A line graph titled 'Mean Severity of Night Heartburn By Study Day For Evaluable Patients,' showing mean severity scores (0 to 3 scale) over approximately 60 days from treatment start. It compares placebo, Lansoprazole 15 mg QD, and Lansoprazole 30 mg QD groups, indicating decreasing mean night heartburn severity with Lansoprazole doses compared to placebo over time.*

FDA Label Image

F53ca2be-a290-4157-ad95-d24dfe3344f9-06 (F53ca2be A290 4157 Ad95 D24dfe3344f9 1)

Lansoprazole 30 mg delayed-release capsules packaging label from Preferred Pharmaceuticals, Inc. The image shows a white carton box with blue and white accents, displaying the brand name Lansoprazole and dosage strength of 30 mg. The label indicates the capsules are for oral use as a prescription drug, and includes the NDC 68788-7742.*

FDA Label Image

F53ca2be-a290-4157-ad95-d24dfe3344f9-07 (F53ca2be A290 4157 Ad95 D24dfe3344f9 2)

Lansoprazole 30 mg delayed-release capsules packaging label from Preferred Pharmaceuticals, Inc. The image shows a white box featuring the brand and generic name Lansoprazole, with strength 30 mg indicated. The box displays typical pharmaceutical branding in green, blue, and orange colors with capsule imagery and dosage form noted as oral use. The label includes the NDC number 68788-7742.*

FDA Label Image

Image (F53ca2be A290 4157 Ad95 D24dfe3344f9 7)

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.